We are live on ! Find out more
CDMO

Avid Bioservices, Inc. Common Stock
CDMO

Delisted

CDMO was delisted on the 4th of February, 2025.

Back to rankings

61 hedge funds and large institutions have $26M invested in Avid Bioservices, Inc. Common Stock in 2017 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 21 increasing their positions, 10 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

188% more call options, than puts

Call options by funds: $49K | Put options by funds: $17K

173% more capital invested

Capital invested by funds: $9.53M → $26M (+$16.5M)

110% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 10

9% less funds holding

Funds holding: 67 → 61 (-6)

15% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 13

Holders
61
Holders Change
-6
Holders Change %
-8.96%
% of All Funds
1.52%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
11
Increased
21
Reduced
10
Closed
13
Calls
$49K
Puts
$17K
Net Calls
+$32K
Net Calls Change
+$23K

Top Buyers

Rank Fund Capital Flow
1
TSP
Tappan Street Partners
Illinois
+$3.06M
2
BlackRock
BlackRock
New York
+$2.87M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$896K
4
KCM
Kennedy Capital Management
Missouri
+$553K
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$347K

Top Sellers

Rank Fund Capital Flow
1
FM
Fondren Management
Texas
-$1.39M
2
Squarepoint
Squarepoint
New York
-$204K
3
Goldman Sachs
Goldman Sachs
New York
-$98K
4
FIM
Freedom Investment Management
Connecticut
-$57.7K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$34.2K
Name Holding Trade Value Shares
Change 		Change in
Stake
KCM
1
Kennedy Capital Management
Missouri
$5.71M +$553K +164,949 +15%
TSP
2
Tappan Street Partners
Illinois
$4.19M +$3.06M +914,286 New
Vanguard Group
3
Vanguard Group
Pennsylvania
$4.04M +$896K +267,432 +43%
BlackRock
4
BlackRock
New York
$3.92M +$2.87M +855,437 New
Renaissance Technologies
5
Renaissance Technologies
New York
$2.01M +$289K +86,258 +24%
Geode Capital Management
6
Geode Capital Management
Massachusetts
$940K +$165K +49,259 +32%
FIM
7
Freedom Investment Management
Connecticut
$678K -$57.7K -17,223 -10%
Acadian Asset Management
8
Acadian Asset Management
Massachusetts
$473K +$347K +103,444 New
Jacobs Levy Equity Management
9
Jacobs Levy Equity Management
New Jersey
$388K +$24.1K +7,200 +9%
BAS
10
Brown Advisory Securities
Maryland
$379K +$278K +82,857 New
QI
11
QS Investors
New York
$329K – – –
California Public Employees Retirement System
12
California Public Employees Retirement System
California
$314K – – –
Morgan Stanley
13
Morgan Stanley
New York
$281K +$158K +47,023 +327%
Commonwealth Equity Services
14
Commonwealth Equity Services
Massachusetts
$273K +$2.15K +643 +1%
Northern Trust
15
Northern Trust
Illinois
$272K +$21.5K +6,423 +12%
Russell Investments Group
16
Russell Investments Group
United Kingdom
$210K +$154K +46,064 New
VKH
17
Virtu KCG Holdings
New York
$156K +$103K +30,852 +941%
Wells Fargo
18
Wells Fargo
California
$149K +$91.1K +27,178 +496%
Citadel Advisors
19
Citadel Advisors
Florida
$134K +$98.4K +29,379 New
Bank of New York Mellon
20
Bank of New York Mellon
New York
$129K +$1.79K +533 +2%
AQR Capital Management
21
AQR Capital Management
Connecticut
$125K – – –
BBI
22
Baxter Bros Inc
Connecticut
$98K +$5.46K +1,629 +8%
NCCM
23
Nine Chapters Capital Management
New Jersey
$88K -$24.2K -7,215 -27%
State Street
24
State Street
Massachusetts
$67K – – –
BIP
25
Brandes Investment Partners
California
$58K +$42.6K +12,729 New
1
2 3

CDMO Hedge Fund Activity: Q1 2017 in Review

61 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Avid Bioservices, Inc. Common Stock (CDMO) for Q1 2017, worth a combined $26M — up 173% from $9.53M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of CDMO and 11 opened new positions — a net loss of 2 holders — while 10 trimmed existing stakes and 21 added.

The largest buyer was Tappan Street Partners, opening a new position worth an estimated $3.06M. The largest seller was Fondren Management, exiting entirely with an estimated $1.39M sold.

  • 61 institutional investors held Avid Bioservices, Inc. Common Stock (CDMO) as of Q1 2017, down from 67 in Q4 2016.
  • Funds reported $26M of Avid Bioservices, Inc. Common Stock stock for Q1 2017, up 173% quarter-over-quarter.
  • 11 funds opened new Avid Bioservices, Inc. Common Stock positions in Q1 2017 and 13 closed out, a net change of -2 holders.
  • The largest Avid Bioservices, Inc. Common Stock buyer in Q1 2017 was Tappan Street Partners, an estimated $3.06M added.
  • The largest Avid Bioservices, Inc. Common Stock seller in Q1 2017 was Fondren Management, an estimated $1.39M sold.

Based on aggregated 13F filings for Q1 2017.